Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024
- PMID: 40682456
- PMCID: PMC12273254
- DOI: 10.2807/1560-7917.ES.2025.30.28.2500452
Spread of the FAR-MRSA clone, a fusidic acid- and meticillin-resistant Staphylococcus aureus ST121, Europe, 2014 to 2024
Abstract
We describe the genetic characteristics of a fusidic acid- and meticillin-resistant Staphylococcus aureus (MRSA) clone widespread in Europe, based on whole genome sequences from 317 isolates. The clone is causing impetigo and other skin and soft tissue infections, primarily in young children. Comparison with publicly available S. aureus ST121 sequences showed that the clone is clearly distinct from previously described ST121 clones. European and other international readers should be aware of the emergence of this community-acquired MRSA clone.
Keywords: Methicillin-resistance; Staphylococcus aureus; fusidic acid resistance; impetigo; international clone; multi-resistance.
Conflict of interest statement
Figures




References
-
- Vendrik KEW, Kuijper EJ, Dimmendaal M, Silvis W, Denie-Verhaegh E, de Boer A, et al. An unusual outbreak in the Netherlands: community-onset impetigo caused by a meticillin-resistant Staphylococcus aureus with additional resistance to fusidic acid, June 2018 to January 2020. Euro Surveill. 2022;27(49):2200245. 10.2807/1560-7917.ES.2022.27.49.2200245 - DOI - PMC - PubMed
-
- Yin N, Michel C, Makki N, Deplano A, Milis A, Prevost B, et al. Emergence and spread of a mupirocin-resistant variant of the European epidemic fusidic acid-resistant impetigo clone of Staphylococcus aureus, Belgium, 2013 to 2023. Euro Surveill. 2024;29(19):2300668. 10.2807/1560-7917.ES.2024.29.19.2300668 - DOI - PMC - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical